About Annovis Bio (ANVS)
Annovis Bio, Inc. operates as a biotechnology company. The Company develops drugs for alzheimer's and parkinson's disease, including the orphan indication dementia and alzheimer's in down syndrome. Annovis Bio serves customers in the State of Pennsyl... Read more
- USD2.34
- USD2.48
- USD2.34
- USD17.88
- -9.60%
- --
- 191.02k
- 558.65k
- 40M
- 1.11
- -70.80%
Stock News
3 hours ago
Dow Jones Futures: Trump Tariffs Back In Focus; Tesla Rival Uber Leads 5 Stocks In Buy Zones
Yahoo
10 hours ago
Happiness researcher shares his '90-second rule' to live a better, more fulfilled life—it helps when you're angry or upset
CNBC
10 hours ago
Retirees are flocking to these 10 U.S. states—No. 1 offers low taxes and sunny weather
CNBC
11 hours ago
Fast-casual restaurants lean on loyalty programs to offset consumer pullback
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
